Find the latest clinical trials by condition, location & phase
Browse and search for drug information and related clinical trials
Explore a comprehensive list of organizations, including their profiles and details.
Latest updates on clinical trials, pharmaceuticals, and healthcare companies
Stay informed with timely notifications on clinical trials and research advancements.
No overview information available.
No background information available.
No indication information available.
No associated conditions information available.
Enterprise Therapeutics' ETD001, an inhaled ENaC blocker, is currently in Phase 2 clinical trials to assess its impact on lung function in cystic fibrosis patients.
Enterprise Therapeutics has appointed Annabella Amatulli as Head of Regulatory Affairs to bolster its strategic leadership team.